News for 'CGUD' - (Com-Guard, Inc. Hires Wall Street

New Post Public Reply Private Reply Replies (0) Message Board
wholelotamoney
News for 'CGUD' - (Com-Guard, Inc. Hires Wall Street Branding to Assist in Branding Phase) 


ENCINITAS, Calif., Sept. 18, 2012 /PRNewswire via COMTEX/ -- Com-Guard.com, 
Inc. (CGUD.pk), the technology  security company years is excited to announce the 
hiring of Wall Street Branding Inc. as its strategic consultant to help and 
assist in the acquisition and  funding for the various upcoming projects that 
Com-Guard, Inc. is planning. Dr. Edward W. Savarese, CEO, stated "we are 
delighted to bring in Wall Street Branding's extensive background in the small 
cap market and look forward to their assistance in executing our  business plan ". 

Wall Street Branding, Inc. is an internet and social networking company that 
uses contemporary methods to build awareness throughout the internet and makes 
it easy for investors to find out the true facts about the  company's they 
represent. Wall Street Branding has been extremely successful in directing 
awareness to the companies in which they represent. Wall Street Branding has 
over 13 years of experience in the  small cap market and their expertise in 
reaching investors. 

The company has applied for and received a developer's license for the Apple iOS 
mobile platform and it currently sells 2 products related to security, 
DataCrypt(TM) and Missed Call Tracker. 

This press release contains forward-looking statements made pursuant to the safe 
harbor provisions of the Private Securities Litigation Act of 1995. They can be 
identified by words such as "anticipates," "intends," "plans," "seeks," 
"believes," "estimates," "expects" and similar references to future periods. 
These statements are based on our current expectations and assumptions regarding 
our business, the economy and other future conditions and they are subject to 
inherent uncertainties, risks and changes in circumstances that are difficult to 
predict. Our actual results may differ materially from those contemplated by 
these statements. We caution you therefore against relying on any of these 
statements. They are neither statements of historical fact nor guarantees or 
assurances of future performance. Statement of future goals and expressions 
reflecting other than historical fact involve risks and uncertainties. The 
actual results the company achieves may differ materially from any 
forward-looking statements due to such risks and uncertainties. These risks and 
uncertainties may cause actual outcomes and results to differ materially from 
expectations in this press release. These and other risks are detailed in 
Com-Guard's Disclosure and Information Statement at www.pinksheets.com and its 
previously filed quarterly reports on Form 10-QSB and its annual report on Form 
10-KSB. Forward-looking statement made in this press release speaks only as of 
the date on which it is made. Factors or events that could cause our actual 
results to differ may emerge from time to time, and it is not possible for us to 
predict all of them. We undertake no obligation to publicly update any 
forward-looking statement, whether as a result of new information, future 
developments or otherwise. 

(C) 2012 Com-Guard.com, Inc. All rights reserved, ComputerSafe® is a registered 
trademark of Com-Guard.com, Inc. in the United States. All other trademarks are 
the property of their respective owners. 

SOURCE Com-Guard.com, Inc. 



www.prnewswire.com 


Copyright (C) 2012 PR Newswire. All rights reserved

Com-Guard.Com Inc (CGUD) Stock Research Links

CGUD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 222

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 198

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 163

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 410

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on Stocks: Applied Materials, Coupang, and Starbucks

Updated Category News Views 176

Market Highlights from CNBC's Final Trades In the latest episode of CNBC's “Halftime Report Final Trades,” Jim Lebenthal from Cerity Partners highlighted a compelling trade with Applied Materials, Inc. (NASDAQ: AMAT), suggesting it's one to watch closely in the current market environment. Applied Materials: Recent Developments Recently, applied materials found itself...

Continue Reading
Investors Urged to Take Action on Biohaven Ltd. Lawsuit

Updated Category News Views 101

Key Details for Biohaven Ltd. Investors Attention investors! If you've acquired securities of Biohaven Ltd. between certain dates, it's crucial to know about an ongoing class action lawsuit that may affect you. Now is the time to ensure your rights are protected. Why You Should Act Now The Rosen Law Firm has announced an important deadline for those who purchased Biohaven...

Continue Reading
ProPhase Labs Inc. Growth Update: Strategies & Innovations

Updated Category News Views 141

ProPhase Labs Inc. Update Overview Diamond Equity Research has recently published a significant update on ProPhase Labs Inc. (NASDAQ: PRPH), shedding light on the company’s strategic initiatives and innovations. This analysis explores ProPhase's evolving business model, its position within the industry, financial performance, and potential market risks. Growth...

Continue Reading
Donaldson Company Reports Record Sales and Ambitious 2026 Goals

Updated Category News Views 216

Donaldson Company Reports Outstanding Results for Fourth Quarter Donaldson Company (NYSE: DCI) has recently provided an impressive overview of its fourth-quarter and full-year fiscal 2025 performance. The company reported remarkable sales figures and notable earnings that reflect its ability to navigate market challenges effectively. With guidance for fiscal 2026 now in...

Continue Reading
Brandywine Realty Trust's 2024 Financial Performance Revealed

Updated Category News Views 189

Brandywine Realty Trust Reports Impressive Results for 2024 In a recent announcement, Brandywine Realty Trust (NYSE: BDN) showcased its financial and operational results for 2024, indicating strong performance across several metrics. As the company evaluates these results, it prepares for an even more promising outlook in 2025. Remarkable Achievements in 2024 Operational...

Continue Reading